Skip to main content
. 2017 May 18;9(14):645–656. doi: 10.4254/wjh.v9.i14.645

Table 3.

Summary of dose constraints by number of fractions

Organ at risk 3 fraction (RAS trial[102]) 5 fraction (RTOG 1112[103]) QUANTEC (1.8-2 Gy per fraction)[104] Toxicity
Liver excluding CTV 700 mL < 15 Gy V 10 < 70% D mean < 30 Gy Radiation induced liver dysfunction
Esophagus D 1 mL < 21 Gy D 0.5 mL < 32 Gy V 35 < 50% Esophagitis
Stomach D 1 mL < 21 Gy D 0.5 mL < 30 Gy D 100 < 35 Gy Ulceration
Kidney D 35% < 15 Gy D mean < 10 Gy D mean < 28 Gy (1.8-2 Gy per fraction) Renal dysfunction
Bowel and duodenum D 1 mL < 21 Gy D 0.5 mL < 30 Gy D 45 < 195 cc Enteritis/fistula
Spinal cord Dmax < 18 Gy D 0.5 mL < 25 Gy Dmax = 45 Myelopathy
Heart D 1 mL, 30 Gy D 30 mL < 30 Gy V 25 < 10% Pericarditis

CTV: Clinical target volume.